Journal of the American College of Surgeons
Volume 209, Issue 5 , Pages 638-644 , November 2009

Laparoscopic Adjustable Gastric Banding for Morbidly Obese Adolescents Affects Android Fat Loss, Resolution of Comorbidities, and Improved Metabolic Status

Abstract presented at the American College of Surgeons 93rd Clinical Congress, Surgical Forum, New Orleans, LA, October 2007, and the Section on Surgery, 59th Annual Meeting of the American Academy of Pediatrics, San Francisco, CA, October 2007.

  • Evan P. Nadler, MD

      Affiliations

    • Division of Pediatric Surgery, New York University School of Medicine, New York, NY
    • Department of Surgery, New York University School of Medicine, New York, NY
    • Corresponding Author InformationCorrespondence address: Evan P Nadler, MD, New York University School of Medicine, 530 First Ave, Suite 10W, New York, NY 10016
    • ,
  • Shivani Reddy, MD

      Affiliations

    • Division of Pediatric Surgery, New York University School of Medicine, New York, NY
    • Department of Surgery, New York University School of Medicine, New York, NY
    • ,
  • Anthony Isenalumhe, MD

      Affiliations

    • Division of Pediatric Surgery, New York University School of Medicine, New York, NY
    • Department of Surgery, New York University School of Medicine, New York, NY
    • ,
  • Heekoung A. Youn, MD

      Affiliations

    • Department of Surgery, New York University School of Medicine, New York, NY
    • ,
  • Valerie Peck, MD

      Affiliations

    • Department of Medicine, New York University School of Medicine, New York, NY
    • ,
  • Christine J. Ren, MD

      Affiliations

    • Department of Surgery, New York University School of Medicine, New York, NY
    • ,
  • George A. Fielding, MD

      Affiliations

    • Department of Surgery, New York University School of Medicine, New York, NY

Received 12 June 2009 ,Revised 24 July 2009 ,Accepted 24 July 2009.

References 

  1. Moo TA, Rubino F. Gastrointestinal surgery as treatment for type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2008;15:153–158
  2. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–749
  3. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA. 2004;291:2847–2850
  4. O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144:625–633
  5. Nadler EP, Youn HA, Ginsburg HB, et al. Short-term results in 53 US obese pediatric patients treated with laparoscopic adjustable gastric banding. J Pediatr Surg. 2007;42:137–141
  6. Nadler EP, Youn HA, Ren CJ, Fielding GA. An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data. J Pediatr Surg. 2008;43:141–146
  7. Gastrointestinal surgery for severe obesity (NIH Consensus Development Conference, March 25-7,1991). Nutrition. 1996;12:397–404
  8. Ren CJ, Fielding GA. Laparoscopic adjustable gastric banding: surgical technique. J Laparoendosc Adv Surg Tech A. 2003;13:257–263
  9. Parikh MS, Fielding GA, Ren CJ. U.S. experience with 749 laparoscopic adjustable gastric bands: intermediate outcomes. Surg Endosc. 2005;19:1631–1635
  10. Yitzhak A, Mizrahi S, Avinoach E. Laparoscopic gastric banding in adolescents. Obes Surg. 2006;16:1318–1322
  11. Silberhumer GR, Miller K, Kriwanek S, et al. Laparoscopic adjustable gastric banding in adolescents: the Austrian experience. Obes Surg. 2006;16:1062–1067
  12. Brancatisano A, Wahlroos S, Brancatisano R. Improvement in comorbid illness after placement of the Swedish Adjustable Gastric Band. Surg Obes Relat Dis. 2008;4:S39–S46
  13. Nguyen NT, Varela E, Sabio A, et al. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg. 2006;203:24–29
  14. Inge T, Wilson KA, Gamm K, et al. Preferential loss of central (trunk) adiposity in adolescents and young adults after laparoscopic gastric bypass. Surg Obes Relat Dis. 2007;3:153–158
  15. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–88714
  16. Carey DG, Pliego GJ, Raymond RL. Body composition and metabolic changes following bariatric surgery: effects on fat mass, lean mass and basal metabolic rate: six months to one-year follow-up. Obes Surg. 2006;16:1602–1608
  17. Dixon JB, O'Brien PE. Obesity and the white blood cell count: changes with sustained weight loss. Obes Surg. 2006;16:251–257
  18. Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6:1396–1402
  19. Moulin de Moraes CM, Mancini MC, de Melo ME, et al. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass. Obes Surg. 2005;15:1287–1291
  20. Chikunguwo S, Brethauer S, Nirujogi V, et al. Influence of obesity and surgical weight loss on thyroid hormone levels. Surg Obes Relat Dis. 2007;3:631–635discussion 635–636
  21. Ferrannini E, Natali A, Bell P, et al. Insulin resistance and hypersecretion in obesity. J Clin Invest. 1997;100:1166–1173
  22. Lee JM, Okumura MJ, Davis MM, et al. Prevalence and determinants of insulin resistance among U.S. adolescents: A population-based study. Diabetes Care. 2006;29:2427–2432
  23. Razani B, Chakravarthy MV, Semenkovich CF. Insulin resistance and atherosclerosis. Endocrinol Metab Clin North Am. 2008;37:603–621viii
  24. Duseja A, Das A, Dhiman RK, et al. Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Ann Hepatol. 2007;6:222–226
  25. Jaskiewicz K, Rzepko R, Sledzinski Z. Fibrogenesis in fatty liver associated with obesity and diabetes mellitus type 2. Dig Dis Sci. 2008;53:785–788
  26. Inge TH, Miyano G, Bean J, et al. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics. 2009;123:214–222
  27. Grundy SM, Brewer HB, Cleeman JI, et al. Conference Participants Definition of metabolic syndrome: report of the National, Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–438
  28. Assmann G, Guerra R, Fox G, et al. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol. 2007;99:541–548

 Disclosure Information: Drs Nadler, Ren, and Fielding are investigators for Allergan, which makes the device used in this study and Drs Ren and Fielding are also on Allergan's speaker's bureau.

 Funded by the Harris Obesity Prevention Effort (HOPE) at NYU.

PII: S1072-7515(09)01201-0

doi: 10.1016/j.jamcollsurg.2009.07.022

Journal of the American College of Surgeons
Volume 209, Issue 5 , Pages 638-644 , November 2009

Article Tools